Dupilumab Reduces Inflammatory Biomarkers in Patients Aged 6 Months to 18 Years With Moderate-to-Severe or Severe Atopic Dermatitis

Lisa Beck,Antonella Muraro,Mark Boguniewicz,Zhen Chen,Noah Levit,Ainara Rodriguez Marco

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2023）

引用 0|浏览14

暂无评分

摘要

Elevated levels of inflammatory biomarkers are observed in atopic dermatitis (AD). Dupilumab is associated with reduction of type 2 inflammatory biomarkers in adults, but data from adolescent and pediatric patients are lacking.

查看译文

关键词

moderate-to-severe atopic dermatitis,biomarkers

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要